Inventor · New York, NY, US

John Robert Coleman

14Patents
8h-index
37Co-inventors
72Inventor score

Filing activity: Feb 2, 1998 → May 26, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US6699696B2 Genetically modified cyanobacteria for the production of ethanol, the constructs and method thereof Emerging Cross-Sectional Technologies 57 Expired
US6306639A Genetically modified cyanobacteria for the production of ethanol, the constructs and method thereof Emerging Cross-Sectional Technologies 40 Expired
US6153590A Biologically active peptides and compositions, their use Human Necessities 36 Expired
US7579323B1 Hemiasterlin analogs Emerging Cross-Sectional Technologies 19 Expired
US6870028B1 Biologically active peptides and compositions, their use Human Necessities 16 Expired
US7772397B2 Biologically active peptides and compositions, their use Human Necessities 16 Active
US7410951B2 Biologically active peptides and compositions, their use Human Necessities 16 Expired
US9476032B2 Attenuated viruses useful for vaccines Emerging Cross-Sectional Technologies 13 Active
US10023845B2 Methods of making modified viral genomes Emerging Cross-Sectional Technologies 2 Active
US9650642B2 Genetically modified cyanobacteria for the production of ethanol Emerging Cross-Sectional Technologies 2 Active
US11162080B2 Attenuated viruses useful for vaccines Emerging Cross-Sectional Technologies 1 Active
US11793870B2 Live attenuated strains of foot and mouth disease modified by deoptimization and uses thereof Chemistry; Metallurgy 0 Active
US12168049B2 Attenuated flaviviruses Emerging Cross-Sectional Technologies 0 Active
US12178869B2 Recombinant virus with codon-pair deoptimized region and uses thereof for the treatment of cancer Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.